Jesse M. Zaretsky

17.7k citations

16 papers · 2.1k indexed · 1 hit paper · h-index 8

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- interferon and immune responses
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Oncology 12
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 8
Immunology 9
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4

Co-authors: Antoni Ribas Daniel Sanghoon Shin Giulia Parisi Siwen Hu‐Lieskovan Thomas G. Graeber Ángel García-Díaz Blanca Homet Moreno Davis Y. Torrejon
Journals: Journal of Clinical Oncology (4 papers)Cancer Immunology Research (3 papers)Nature Methods (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
Partner nations: United States China Switzerland

In The Last Decade

Jesse M. Zaretsky

14 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression 2017 · 1.3k citations

Peers

Countries citing papers authored by Jesse M. Zaretsky

Since Specialization

Citations

This map shows the geographic impact of Jesse M. Zaretsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse M. Zaretsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse M. Zaretsky more than expected).

Fields of papers citing papers by Jesse M. Zaretsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse M. Zaretsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse M. Zaretsky. The network helps show where Jesse M. Zaretsky may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jesse M. Zaretsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jesse M. Zaretsky Line = papers co-authored together Jesse M. Zaretsky links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Safety of administration of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, before curative-intent treatment in patients with HPV16+ oropharyngeal squamous cell carcinoma. Journal of Clinical Oncology ·Sidharth V. Puram, Peter Oppelt, Jessica Ley, Jesse M. Zaretsky, Ryan S. Jackson, Patrik Pipkorn, R. Alex Harbison, Jason T. Rich, Wade L. Thorstad, Nikhil Ram-Mohan, Jennifer De Los Santos, Michael J. Moravan, Anthony J. Apicelli, Jingxia Liu, Franck Baco-Antionali, Andrew K. Short, Steven N. Quayle, Matteo Levisetti, Anish Suri, Douglas R. Adkins	2025	0
2	Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A0201 positive patients with HPV16+ OPSCC. Journal of Clinical Oncology* ·Jesse M. Zaretsky, Jessica Ley, Peter Oppelt, T. Shivaprasad, Thomas F. Barrett, Ryan S. Jackson, Patrik Pipkorn, Randal C. Paniello, Jason T. Rich, Jingxia Liu, Im Yeong Lee, Sam A. Santoro, Wade L. Thorstad, Steven N. Quayle, Raymond J. Moniz, Apollina Goel, Matteo Levisetti, Anish Suri, Sidharth V. Puram, Douglas Adkins	2023	1
3	CABIOS trial: A phase Ib study of cabozantinib and nivolumab in combination with abiraterone in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC). Journal of Clinical Oncology ·Jesse M. Zaretsky, Mary Dellenbaugh-Losse, Muhammad A. Saeed, Bo Peng, Jingqin Luo, I.I. Cherepakhin, Melissa A. Reimers, Russell K. Pachynski	2023	2
4	Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma Science Translational Medicine ·Anusha Kalbasi, 太郎野中, Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes, Agustin Vega-Crespo, Giulia Parisi, Justine Devenney, Christine Nguyen, Davis Y. Torrejon, Daniel Sanghoon Shin, Jesse M. Zaretsky, Robert Damoiseaux, Daniel E. Speiser, Pedro P. López‐Casas, Marisol Quintero, Antoni Ribas	2020	79
5	Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer Clinical Cancer Research ·Siwen Hu‐Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Tristan Grogan, Hira Rizvi, Daniel K. Wells, James Carroll, Amy L. Cummings, John Madrigal, Benjamin Jones, Jaklin Gukasyan, I. Peter Shintaku, Dennis J. Slamon, Steven M. Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B. Garon	2019	56
6	T cell antigen discovery via signaling and antigen-presenting bifunctional receptors Nature Methods ·Alok V. Joglekar, Michael T. Leonard, John D. Jeppson, M Swift, Guideng Li, Stephanie Wong, Songming Peng, Jesse M. Zaretsky, James R. Heath, Antoni Ribas, Michael T. Bethune, David Baltimore	2019	107
7	T cell antigen discovery via trogocytosis Nature Methods ·Guideng Li, Michael T. Bethune, Stephanie Wong, Alok V. Joglekar, Michael T. Leonard, Jessica K. Wang, Jocelyn T. Kim, Donghui Cheng, Songming Peng, Jesse M. Zaretsky, Yapeng Su, Yicheng Luo, James R. Heath, Antoni Ribas, Owen N. Witte, David Baltimore	2019	107
8	Sensitive, NonnDestructive Detection and Analysis of NeoantigennSpecific T Cell Populations from Tumors and Blood SSRN Electronic Journal ·Songming Peng, Jesse M. Zaretsky, Michael T. Bethune, Panagiotis Bourlessas, J.W. Jukema, Xiaozhe Ding, А. Г. Перов, Jung-Woo Kim, Alexander M. Xu, John E. Heath, Won Noh, Jing Zhou, Yapeng Su, Jami McLaughlin, Donghui Cheng, Owen N. Witte, David Baltimore, Antoni Ribas, James R. Heath	2018	1
9	Abstract 4755: Role of PAK4 in cancer immune cell exclusion Cancer Research ·Gabriel Abril-Rodríguez, Catherine S. Grasso, Jesse M. Zaretsky, Beata Berent-Maoz, Siwen Hu‐Lieskovan, Antoni Ribas	2018	1
10	Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer Cancer Immunology Research ·Marios Giannakis, Catherine S. Grasso, Daniel K. Wells, Tsuyoshi Hamada, Xinmeng Jasmine Mu, Michael J. Quist, Jonathan A. Nowak, Reiko Nishihara, Charles M. Connolly, Sachet A. Shukla, William M. Grady, David A. Wheeler, Catherine J. Wu, Jesse M. Zaretsky, Levi A. Garraway, Thomas J. Hudson, Charles S. Fuchs, Antoni Ribas, O. V. Коrniyenko, Shuji Ogino	2018	2
11	Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression Cell Reports ·Ángel García-Díaz, Daniel Sanghoon Shin, Blanca Homet Moreno, Justin D. Saco, Helena Escuin-Ordinas, Gabriel Abril Rodriguez, Jesse M. Zaretsky, Lu Sun, Willy Hugo, Xiaoyan Wang, Giulia Parisi, Cristina Puig-Saus, Davis Y. Torrejon, Thomas G. Graeber, Begonya Comin-Anduix, Siwen Hu‐Lieskovan, Robert Damoiseaux, Roger S. Lo, Antoni Ribas Hit paper breakdown →	2017	1327
12	Abstract NG04: Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations Cancer Research ·Jesse M. Zaretsky, Ángel García-Díaz, Daniel S. Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu‐Lieskovan, Zeynep Eroglu, Davis Y. Torrejon, Paul C. Tumeh, Roger S. Lo, Antoni Ribas	2017	3
13	Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells Cancer Immunology Research ·Blanca Homet Moreno, Jesse M. Zaretsky, Ángel García-Díaz, Jennifer Tsoi, Giulia Parisi, Lídia Robert, Katrina Meeth, Abibatou Ndoye, Marcus Bosenberg, Ashani T. Weeraratna, Thomas G. Graeber, Begoña Comı́n-Anduix, Siwen Hu‐Lieskovan, Antoni Ribas	2016	104
14	PD-1 Blockade Expands Intratumoral Memory T Cells Cancer Immunology Research ·Antoni Ribas, Daniel Sanghoon Shin, Jesse M. Zaretsky, Juliet Frederiksen, Andrew Cornish, Earl Avramis, Elizabeth Seja, Christine Kivork, Janet Siebert, Paula Kaplan‐Lefko, Xiaoyan Wang, Bartosz Chmielowski, John A. Glaspy, Paul C. Tumeh, Thinle Chodon, Dana Pe’er, Begoña Comı́n-Anduix	2016	302
15	TCR use and cytokine response in PD-1 blockade. Journal of Clinical Oncology ·Jesse M. Zaretsky, Steven M. Blum, Arthur Bottois, Ryan Emerson, Antoni Ribas	2015	1
16	Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure Journal for ImmunoTherapy of Cancer ·Daniel S. Shin, Ángel García-Díaz, Jesse M. Zaretsky, Helena Escuin-Ordinas, Siwen Hu‐Lieskovan, Nicolaos Palaskas, Willy Hugo, T-M Lee, Bartosz Chmielowski, Grace Cherry, Beata Berent-Maoz, Thomas G. Graeber, Roger S. Lo, Begonya Comin-Anduix, Antoni Ribas	2015	14

About Jesse M. Zaretsky

Jesse M. Zaretsky is a scholar working on Oncology, Immunology, Cancer Research, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Virus-based gene therapy research (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.5k citations), Cancer Research (183 citations), Pulmonary and Respiratory Medicine (278 citations) and Molecular Biology (518 citations). Jesse M. Zaretsky has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Antoni Ribas, Daniel Sanghoon Shin, Giulia Parisi, Siwen Hu‐Lieskovan, Thomas G. Graeber, Ángel García-Díaz, Blanca Homet Moreno, Davis Y. Torrejon, Robert Damoiseaux and Willy Hugo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Research, Nature Methods, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact